Ombrabulin
- Generic Name
- Ombrabulin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H26N2O6
- CAS Number
- 181816-48-8
- Unique Ingredient Identifier
- 82JB1524Q6
- Background
Ombrabulin has been used in trials studying the treatment of Sarcoma, Neoplasms, Solid Tumor, Neoplasms, Malignant, and Advanced Solid Tumors, among others.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath